Form 8-K - Current report:
SEC Accession No. 0001193125-24-157311
Filing Date
2024-06-07
Accepted
2024-06-07 16:03:00
Documents
13
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d796921d8k.htm   iXBRL 8-K 30608
  Complete submission text file 0001193125-24-157311.txt   153044

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alvr-20240606.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20240606_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20240606_pre.xml EX-101.PRE 11258
16 EXTRACTED XBRL INSTANCE DOCUMENT d796921d8k_htm.xml XML 3620
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 241029207
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)